GlobeStar Therapeutics Corp
company.status.inactiveCIK 1502152fmd_1JQFY6XS4EWS35JA953MKS2FW3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 16, 2010 to Jun 30, 2024, 55 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | – | 0 | 0 | 0 | 0 | – | – | – |
| Cost of revenue | – | – | – | 0 | 0 | 0 | 0 | 0 | – | – |
| Realized investment gains (losses) | – | – | – | 0 | – | – | – | – | – | – |
| Gross profit | – | – | – | 0 | 0 | 0 | (0) | (0) | – | – |
| Research and development | – | – | – | – | – | – | – | 0 | 0 | 0 |
| Total operating expenses | 0 | 1 | 1 | 0 | – | – | – | – | – | – |
| Operating income | (1) | (0) | (1) | (0) | (0) | (0) | (0) | (9) | (1) | (2) |
| Interest expense | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest and investment income | – | – | – | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | (0) | (1) | – | – | – | – | – | (1) | (0) | (0) |
| Income before taxes | (0) | 0 | (0) | (2) | – | – | – | – | – | – |
| Income tax expense | – | – | – | – | 0 | 0 | – | – | – | – |
| Net income | (1) | (1) | (1) | (2) | (1) | (1) | (1) | (10) | (1) | (2) |
| Net income to common shareholders | – | – | – | – | (1) | (2) | (1) | – | – | – |